Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Conference attendance

1 Mar 2018 07:00

RNS Number : 3044G
Collagen Solutions PLC
01 March 2018
 

 

1 March 2018

Collagen Solutions to Present at Canaccord Genuity Musculoskeletal Conference &

Exhibit at American Academy of Orthopaedic Surgeons Conference

Dates: 6-9 March 2018

 

 

Collagen Solutions Plc (AIM: COS), (the "Company"), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine, including orthopaedic, dental, wound care, and cardiovascular applications, confirms two forthcoming conferences it will be attending in New Orleans, Louisiana, USA, between 6-9 March 2018.

· Jamal Rushdy, CEO, to present at the Canaccord Genuity Musculoskeletal Conference (6 March)· Company to Exhibit at the American Academy of Orthopaedic Surgeons "AAOS" Annual Conference (7-9 March)

 

AAOS is the world's largest and most prestigious annual orthopaedic meeting so attending this conference and presenting at the accompanying Canaccord Genuity Musculoskeletal Conference provides access to an extremely wide range of investors and manufacturers in areas of spine, trauma/extremities, foot and ankle, and sports medicine.

 

Commenting on the conferences, Jamal Rushdy, CEO said: "We are pleased to have the opportunity to present at the Canaccord Genuity Musculoskeletal Conference, where we will highlight our recently announced positive 8-year follow-on data from ChondroMimetic® demonstrating durable cartilage regeneration in keyhole knee surgery. We are also excited to be a first-time exhibitor at AAOS and to showcase our OEM capabilities and propriety device licensing opportunities to investors and industry partners. These meetings provide the opportunity to actively engage with orthopaedic companies on a global scale. We will also be providing hands-on demonstrations of prototypes for our Bone Graft Substitute, ChondroMimetic® Cartilage Repair Scaffold, and Fibrillar Collagen development programmes."

 

 

 

Collagen Solutions PlcJamal Rushdy, Chief Executive OfficerHilary Spence, Chief Financial OfficerLisa Baderoon, Head of Investor Relations

Tel: +44 (0) 141 648 9100Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com

Cenkos Securities plc (NOMAD and Broker)Stephen KeysSteve Cox

Tel: +44 (0) 207 397 8900

Walbrook PRAnna DunphyHelen Cresswell

Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.comMob: +44 (0) 7876 741 001

 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com

The American Academy of Orthopedic Surgeons (AAOS)

AAOS is an orthopedic organisation. Founded at Northwestern University in 1933, as of 2015 AAOS had grown to include about 39,000 members. The group provides education and practice management services for orthopedic surgeons and allied health professionals. The AAOS also lobbies and works on public education. The AAOS describes itself as "the world's largest medical association of musculoskeletal specialists.

For more information go to: www.aaos.org

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZMGZZNRFGRZM
Date   Source Headline
10th Mar 20152:56 pmRNSDirector/PDMR Shareholding
10th Mar 20157:03 amRNSRegulatory Approvals for Collagen Solutions Client
10th Mar 20157:03 amRNSTrading Statement and Acquisition Update
9th Jan 20157:00 amRNSInvestor Presentation
7th Jan 20154:04 pmRNSHolding(s) in Company
7th Jan 20157:00 amRNSCEO Presents at OneMedForum
5th Jan 20157:00 amRNSContract signed with Globus Medical Inc.
22nd Dec 20147:00 amRNSNew contract to supply Desu Medical
17th Dec 201410:54 amRNSHolding(s) in Company
15th Dec 20147:00 amRNSContract signed with Kyeron
12th Dec 201410:50 amRNSHolding(s) in Company
10th Dec 20147:00 amRNSSouthern Lights Biomaterials Acquisition Completed
24th Nov 201411:48 amRNSGrant of Options
21st Nov 20147:30 amRNSSchedule 1 - Collagen Solutions Plc
21st Nov 20147:00 amRNSAcquisition
21st Nov 20147:00 amRNSChange of Adviser
21st Nov 20147:00 amRNSHalf Yearly Report
22nd Oct 201412:30 pmRNSHolding(s) in Company
17th Oct 20147:00 amRNSJellagen Collaboration
10th Sep 201412:23 pmRNSHolding(s) in Company
3rd Sep 20147:00 amRNSAppointment to Scientific Advisory Board
27th Aug 201411:52 amRNSResult of AGM
29th Jul 20143:19 pmRNSHolding(s) in Company
18th Jul 20147:00 amRNSPosting of Annual Report & Notice of AGM
10th Jul 20147:00 amRNSFinal Results
3rd Jul 20147:00 amRNSChange of Registered Office
10th Jun 20147:00 amRNSExclusive Licencing of Intellectual Property
19th May 20147:00 amRNSProfessor Robert Brown joins as Scientific Adviser
15th May 20147:00 amRNSExcellagen® enters new clinical trial
26th Mar 201410:48 amRNSHolding(s) in Company
3rd Mar 20147:00 amRNSAppointment of Director
27th Dec 201312:25 pmRNSDirector Shareholding
27th Dec 201311:58 amRNSResult of GM
17th Dec 201310:00 amRNSAnnouncement by Cardium Therapeutics
16th Dec 20139:03 amRNSSchedule 1 - Healthcare Investment Opportunities
10th Dec 20137:00 amRNSProposed acquisition
10th Dec 20137:00 amRNSHalf Yearly Report
19th Aug 201311:06 amRNSHolding(s) in Company
1st Aug 20131:43 pmRNSHolding(s) in Company
2nd May 201312:00 pmRNSHolding(s) in Company
22nd Apr 201312:19 pmRNSHolding(s) in Company
9th Apr 201310:57 amRNSHolding in Company
8th Apr 20135:41 pmRNSHolding(s) in Company
5th Apr 20137:00 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.